Bao Lam Thai Tran
Bao Lam Thai Tran is an expert in Cardiology at Can Tho University (Vietnam). Bao Lam Thai Tran has authored 10 publications, the most recent in 2025. SLR score: 21 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Genetics - Public Health - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2022 - 2025
Number : 10
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The prognostic value of <i>AGTR1</i> A1166C gene polymorphism in all-cause mortality and heart failure in patients with acute myocardial infarction OpenAlex W4406679000 — genes, mortality, myocardial infarction, heart failure, heart, polymorphism, genetic, genotype | J Renin Angiotensin Aldosterone Syst | 2025 | 0 |
| Losartan and dapagliflozin combination therapy in reducing uric acid level compared to monotherapy in patients with heart failure. PMID 39624121 — diabetes mellitus, uric acid, serum, heart failure, heart, dyslipidemias, losartan, therapeutics, diabetes mellitus, type 2 | PeerJ | 2024 | 2 |
| Treatment efficacy of febuxostat compared with allopurinol in hyperuricemia patients with hypertensive: A randomized, single-blind controlled trial OpenAlex W4398208892 — treatment outcome, hyperuricemia, allopurinol, therapeutics, febuxostat | Journal of Applied Pharmaceutical Science | 2024 | 0 |
| Effectiveness of clinical pharmacist intervention on medication adherence in patients with chronic obstructive pulmonary disease - A randomized controlled study. PMID 37931404 — pharmacists, pulmonary disease, chronic obstructive, medication adherence, lung diseases, counseling, education, lung diseases, obstructive, patient education as topic | Patient Educ Couns | 2023 | 0 |
| The combination of CYP2C19 polymorphism and inflammatory cell ratios in prognosis cardiac adverse events after acute coronary syndrome. PMID 37920809 — prognosis, drug-related side effects and adverse reactions, cells, genes, polymorphism, genetic, lymphocytes, cross-sectional studies, acute coronary syndrome, real-time polymerase chain reaction, cytochrome p-450 cyp2c19 | Int J Cardiol Cardiovasc Risk Prev | 2023 | 5 |
LeadR Networks
Main global connection map